Archford Capital Strategies’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,792
Closed -$419K 281
2022
Q1
$419K Buy
3,792
+30
+0.8% +$3.17K 0.09% 201
2021
Q4
$389K Sell
3,762
-258
-6% -$29.9K 0.09% 218
2021
Q3
$504K Buy
4,020
+60
+2% +$7.77K 0.12% 187
2021
Q2
$492K Buy
3,960
+654
+20% +$82.1K 0.12% 178
2021
Q1
$416K Buy
3,306
+139
+4% +$16.3K 0.11% 199
2020
Q4
$379K Sell
3,167
-65
-2% -$7.16K 0.09% 209
2020
Q3
$336K Buy
3,232
+12
+0.4% +$1.21K 0.09% 205
2020
Q2
$295K Sell
3,220
-77
-2% -$7.38K 0.09% 207
2020
Q1
$297K Buy
3,297
+294
+10% +$31.3K 0.12% 181
2019
Q4
$341K Buy
+3,003
New +$330K 0.12% 186
2019
Q3
Sell
-478
Closed -$47K 404
2019
Q2
$47K Sell
478
-5,945
-93% -$543K 0.02% 284
2019
Q1
$585K Sell
6,423
-42
-0.6% -$3.76K 0.22% 132
2018
Q4
$588K Buy
6,465
+145
+2% +$13.6K 0.24% 123
2018
Q3
$622K Sell
6,320
-1,321
-17% -$122K 0.23% 125
2018
Q2
$654K Sell
7,641
-4,863
-39% -$406K 0.23% 124
2018
Q1
$1.01M Hold
12,504
0.42% 75
2017
Q4
$1.01M Buy
12,504
+26
+0.2% +$2.08K 0.38% 83
2017
Q3
$970K Sell
12,478
-938
-7% -$77.9K 0.36% 97
2017
Q2
$1.19M Sell
13,416
-209
-2% -$17.6K 0.47% 71
2017
Q1
$1.1M Sell
13,625
-503
-4% -$39.3K 0.41% 81
2016
Q4
$1.01M Sell
14,128
-1,203
-8% -$94.5K 0.42% 86
2016
Q3
$1.32M Buy
15,331
+46
+0.3% +$4.01K 0.55% 55
2016
Q2
$1.33M Buy
15,285
+542
+4% +$43.8K 0.7% 37
2016
Q1
$1.11M Buy
14,743
+475
+3% +$35.8K 0.53% 59
2015
Q4
$1.1M Buy
14,268
+552
+4% +$41.6K 0.5% 60
2015
Q3
$918K Sell
13,716
-39
-0.3% -$2.87K 0.69% 39
2015
Q2
$1.02M Buy
13,755
+1,137
+9% +$86.9K 0.73% 37
2015
Q1
$984K Buy
12,618
+10,827
+605% +$821K 0.68% 47
2014
Q4
$129K Buy
1,791
+1,230
+219% +$85.4K 0.09% 137
2014
Q3
$35K Hold
561
0.03% 236
2014
Q2
$35.8K Sell
561
-121
-18% -$7.35K 0.03% 243
2014
Q1
$42K Buy
+682
New +$39.7K 0.04% 239

Other funds holding MDT